Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Riess

Showing results (51-60 of 136) with videos related to

Pageof 14
Sort By:
Clinical Lung Cancer|February 19, 2019
Increased Galectin-1 Expression in Thymic Epithelial TumorsJonathan W Riess, Christina S Kong, Robert B West, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 18, 2014
Diffuse high intensity PD-L1 staining in thymic epithelial tumorsSukhmani K Padda, Jonathan W Riess, Erich J Schwartz, et al.
The Oncologist|September 8, 2023
Insights of Clinical Significance From 109 695 Solid Tumor Tissue-Based Comprehensive Genomic ProfilesAndreas M Heilmann, Jonathan W Riess, Margaret McLaughlin-Drubin, et al.
Cancer Chemotherapy and Pharmacology|May 16, 2021
Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumorsThomas J Semrad, Edward J Kim, I-Yeh Gong, et al.
Clinical Lung Cancer|October 17, 2022
A Common Cell of Origin for Inflammatory Myofibroblastic Tumor and Lung Adenocarcinoma with ALK rearrangementVasyl Nesteryuk, Omar Hamdani, Raymond Gong, et al.
Metabolites|October 28, 2025
Longitudinal Plasma Lipidomics Reveals Distinct Signatures Following Surgery in Patients with GlioblastomaJohn Paul Aboubechara, Yin Liu, Oliver Fiehn, et al.
Cancer Treatment and Research Communications|May 16, 2020
A PHASE IIA STUDY REPOSITIONING DESIPRAMINE IN SMALL CELL LUNG CANCER AND OTHER HIGH-GRADE NEUROENDOCRINE TUMORSJonathan W Riess, Nadine S Jahchan, Millie Das, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2017
Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 TrialJohn V Hegde, Narek Shaverdian, Carol Felix, et al.
JTO Clinical and Research Reports|April 6, 2023
Brief Report: High Levels of CD47 Expression in Thymic Epithelial TumorsThomas Yang Sun, Brandon Nguyen, Simon B Chen, et al.
Investigational New Drugs|September 10, 2013
Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancerCheryl Ho, Angela M Davies, Randeep S Sangha, et al.
Pageof 14

Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
Clinical Lung Cancer|February 19, 2019
Increased Galectin-1 Expression in Thymic Epithelial TumorsJonathan W Riess, Christina S Kong, Robert B West, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 18, 2014
Diffuse high intensity PD-L1 staining in thymic epithelial tumorsSukhmani K Padda, Jonathan W Riess, Erich J Schwartz, et al.
The Oncologist|September 8, 2023
Insights of Clinical Significance From 109 695 Solid Tumor Tissue-Based Comprehensive Genomic ProfilesAndreas M Heilmann, Jonathan W Riess, Margaret McLaughlin-Drubin, et al.
Cancer Chemotherapy and Pharmacology|May 16, 2021
Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumorsThomas J Semrad, Edward J Kim, I-Yeh Gong, et al.
Clinical Lung Cancer|October 17, 2022
A Common Cell of Origin for Inflammatory Myofibroblastic Tumor and Lung Adenocarcinoma with ALK rearrangementVasyl Nesteryuk, Omar Hamdani, Raymond Gong, et al.
Metabolites|October 28, 2025
Longitudinal Plasma Lipidomics Reveals Distinct Signatures Following Surgery in Patients with GlioblastomaJohn Paul Aboubechara, Yin Liu, Oliver Fiehn, et al.
Cancer Treatment and Research Communications|May 16, 2020
A PHASE IIA STUDY REPOSITIONING DESIPRAMINE IN SMALL CELL LUNG CANCER AND OTHER HIGH-GRADE NEUROENDOCRINE TUMORSJonathan W Riess, Nadine S Jahchan, Millie Das, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2017
Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 TrialJohn V Hegde, Narek Shaverdian, Carol Felix, et al.
JTO Clinical and Research Reports|April 6, 2023
Brief Report: High Levels of CD47 Expression in Thymic Epithelial TumorsThomas Yang Sun, Brandon Nguyen, Simon B Chen, et al.
Investigational New Drugs|September 10, 2013
Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancerCheryl Ho, Angela M Davies, Randeep S Sangha, et al.
Pageof 14